Dr. Jeremy Katzen, a clinical instructor of medicine at the University of Pennsylvania, has received the National Institutes of Health K08 Clinical Investigator Award.
Katzen’s research aims to contribute to an improved scientific understanding of cell biology of the respiratory system while discovering new potential therapeutic possibilities for respiratory disorders. In particular, his work focuses on the impairment process of alveolar type-2 cells and how it could be linked to the initiation and progression of lung fibrosis.
Katzen said he hopes his research will “both further our field and lead to novel therapies for patients living with pulmonary fibrosis.”
Katzen, a 2019 Pulmonary Fibrosis Foundation (PFF) scholar, will receive three to five years of research mentorship as part of the K08 career development program.
The PFF Scholars program specializes in promoting early-stage researchers focused on pulmonary fibrosis.
“We are proud to congratulate Dr. Katzen on his K08 award and look forward to his ongoing work in pulmonary fibrosis research,” said Dr. Gregory Cosgrove, Chief Medical Officer of the PFF in a statement.
Filed Under: Drug Discovery and Development
